Tumor necrosis factor-alpha (TNF-α) enhances functional thermal and chemical responses of TRP cation channels in human synoviocytes by unknown
BioMed CentralMolecular Pain
ssOpen AcceResearch
Tumor necrosis factor-alpha (TNF-α) enhances functional thermal 
and chemical responses of TRP cation channels in human 
synoviocytes
Mikhail Y Kochukov1, Terry A McNearney1,2,3, Huaizhi Yin1, Liping Zhang4, 
Fei Ma4, Larissa Ponomareva4, Sarah Abshire4 and Karin N Westlund*4
Address: 1Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, Texas USA, 2Department of Internal 
Medicine, University of Texas Medical Branch, Galveston, Texas USA, 3Department of Microbiology and Immunology, University of Texas Medical 
Branch, Galveston, Texas USA and 4Department of Physiology, University of Kentucky Chandler Medical Center, Lexington, Kentucky USA
Email: Mikhail Y Kochukov - mykochuk@utmb.edu; Terry A McNearney - tmcnearn@utmb.edu; Huaizhi Yin - hyin@utmb.edu; 
Liping Zhang - lzhanh@uky.edu; Fei Ma - fei.ma@uky.edu; Larissa Ponomareva - ponomala@ucmail.uc.edu; 
Sarah Abshire - Sarah.Abshire@uky.edu; Karin N Westlund* - kwhigh2@uky.edu
* Corresponding author    
Abstract
Background: We have shown functional expression of several TRP channels on human synovial
cells, proposing significance in known calcium dependent proliferative and secretory responses in
joint inflammation. The present study further characterizes synoviocyte TRP expression and
activation responses to thermal and osmotic stimuli after pre-treatment with proinflammatory
mediator tumor necrosis factor alpha (TNF-α, EC50 1.3221 × 10-10g/L).
Results: Fluorescent imaging of Fura-2 loaded human SW982 synoviocytes reveals immediate and
delayed cytosolic calcium oscillations elicited by (1) TRPV1 agonists capsaicin and resiniferatoxin
(20 – 40% of cells), (2) moderate and noxious temperature change, and (3) osmotic stress TRPV4
activation (11.5% of cells). TNF-alpha pre-treatment (1 ng/ml, 8 – 16 hr) significantly increases
(doubles) capsaicin responsive cell numbers and [Ca2+]i spike frequency, as well as enhances
average amplitude of temperature induced [Ca2+]i responses. With TNF-alpha pre-treatment for 8,
12, and 16 hr, activation with 36 or 45 degree bath solution induces bimodal [Ca2+]i increase
(temperature controlled chamber). Initial temperature induced rapid transient spikes and
subsequent slower rise reflect TRPV1 and TRPV4 channel activation, respectively. Only after
prolonged TNF-alpha exposure (12 and 16 hr) is recruitment of synoviocytes observed with
sensitized TRPV4 responses to hypoosmolarity (3–4 fold increase). TNF-alpha increases TRPV1 (8
hr peak) and TRPV4 (12 hr peak) immunostaining, mRNA and protein expression, with a TRPV1
shift to membrane fractions.
Conclusion: TNF-α provides differentially enhanced synoviocyte TRPV1 and TRPV4 expression
and [Ca2+]i response dependent on the TRP stimulus and time after exposure. Augmented
relevance of TRPV1 and TRPV4 as inflammatory conditions persist would provide calcium mediated
cell signaling required for pathophysiological responses of synoviocytes in inflammatory pain states.
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Temperature sensitive transient receptor potential (TRP)
channels belonging to the V- (or vanilloid related) sub-
family are widely expressed in mammalian cells. Four
members of this subfamily, TRPV1–4 conduct mono- and
di-valent cations when activated by temperatures ranging
from > 23°C (TRPV3 and TRPV4) to > 43°C (TRPV1) or >
53°C (TRPV2). In addition, TRPV1–4 function as impor-
tant membrane sensors for extracellular chemical,
osmotic, or mechanical stimuli. TRPV1 channels are acti-
vated by low pH (< 5.9) and endovanilloids. TRPV4 and
TRPV2 respond to cellular swelling and mechanical stim-
ulation. TRPV1 and TRPV4 are activated by anandamide
and arachidonic acid metabolites [1-4]. Other TRP family
channels also respond to chemical (icilin and camphor,
TRPA1 and TRPV3) and menthol or cold stimulation
(TRPM8, < 19°C). This ligand promiscuity supports an
important role of TRP channels during episodes of acute
or chronic inflammation, where dramatic changes in the
extracellular environment impact the physiological and
chemical homeostasis.
Several recent studies have demonstrated that neuronal
growth factors and proinflammatory chemokines and
cytokines can increase the physiologic response of TRP
channels [5-8] and emphasized the enhancing role of TRP
channels in chronic inflammation [3,8-10]. In a previous
study [11] we showed functional expression of thermal
and chemical sensitive (TRPV1, TRPV4, TRPA1) TRP chan-
nels on SW982 clonal and primary human synovial cells.
We have proposed a significant role for TRP in mediation
of calcium dependent proliferative and secretory
responses of synoviocytes during joint inflammation. The
present study supports our hypothesis demonstrating
increases in thermal and osmotic sensitive TRP channel
mediated responses after exposure to proinflammatory
modulator tumor necrosis factor alpha (TNF-α).
TNF-α is found in abundance in synovial fluid of patients
with arthritis [12], and the receptors for TNF-α are found
on synoviocytes harvested from patient tissue or synovial
fluid [13,14]. It is reported by Youn and colleagues [14]
that upon TNF-α stimulation of synoviocytes harvested
from patients, the cells proliferate and the expression of
TNFR2 increases dose dependently, reaching a maximal
level after 24 h of stimulation. In contrast, the levels of
TNFR1 transcripts decrease up to 12 h after TNF-α stimu-
lation in a time-dependent manner. TNF-α very effectively
increases chemokine production in fibroblast-like synovi-
ocytes harvested from arthritis patients [15]. TNF-α has
been shown to be a first line initiator of inflammatory
responses in joints since synovial lining cells express TNF-
α prior to the appearance of other cytokines in a collagen
induced arthritis model [16].
Results
TNF-α sensitizes synoviocyte TRPV1 to capsaicin
Synoviocyte responsiveness to a chemical TRPV1 agonist
(capsaicin, 1 μM) was tested by monitoring intracellular
calcium ([Ca2+]i) mobilization in control (vehicle treated)
and TNF-α pretreated cells. Numerical values for the per-
cent of cells responding, average peak amplitude and
duration are provided in Additional file 1, as well as the
dose response curve for TNF-α (range 10-13 – 10-6 g/L). Fig-
ures 1A and 1B show calcium imaging data acquired from
representative control and TNF-α treated cells before and
after applications of 1 μM capsaicin. Pre-treatment with
TNF-α (1 ng/ml) caused a significantly increased number
of individually responsive cells and increased mean spike
amplitude and duration, compared to cells induced by
capsaicin alone (Additional file 1). Capsaicin induced
Response of human SW982 synoviocytes to capsaicinFigure 1
Response of human SW982 synoviocytes to capsai-
cin. Recordings of [Ca2+]i changes in human SW982 synovio-
cytes in response to TRPV1 agonist capsaicin (1 μM, added at 
the time indicated by bar). (A) control (vehicle treated), n = 
82 cells. (B) TNF-α pre-treatment (1 ng/ml, 8 hr), n = 35 
cells.Page 2 of 16
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antagonist capsazepine in both control and TNF-α-
treated samples, thus confirming the specificity of TNF-α-
mediated vanilloid receptor sensitization. The TNF-α sen-
sitizing effect on TRPV1 activation was evident in the con-
centration range of 1–50 ng/ml TNF-α after 8 to 16 hr
incubations (Additional file 1). No enhancement of tem-
perature induced responses (from > 23°C to > 43°C)
occurred at lower TNF-α concentrations (10, 100 pg/ml;
Additional file 1). Pre-treatment with higher doses of
TNF-α (> 50 ng/ml) or longer incubation times (16 hr)
did not produce further increase in the number of respon-
sive cells or spike amplitude and duration.
TNF-α facilitates noxious thermal-induced calcium 
response
TNF-α induced sensitization of TRPV1 was further dem-
onstrated by observing increased synoviocyte response to
high-degree bath temperature. As shown in our earlier
experiments [11], synoviocytes respond to rapid applica-
tion of media heated to the noxious (45°C) range with a
TRPV1 channel-mediated increase in [Ca2+]i. Figure 2A
illustrates the typical synoviocyte response to prolonged
45°C hyperthermia with apparently two-waves of calcium
changes. First peak and declining phases most likely rep-
resent the TRPV1 channel activation and subsequent
desensitization. The nature of the second calcium wave
was attributed to either gradual TRPV4 sensitization or
non-specific membrane conductance changes. Therefore,
we measured and reported the first [Ca2+]i peak from its
initiation to the beginning of the second rising phase to
quantify the TRPV1-mediated response to noxious ther-
mal stimulation. Figures 2B and 2C, demonstrate that
both maximum and average amplitudes of [Ca2+]i changes
were significantly increased after TNF-α pretreatment (1
ng/ml, 8–16 hr). TRPV4 responses were characterized
with hypoosmolar physiological saline (see below).
"Moderate" temperature activates synoviocyte calcium 
response: Role of TRPV3 and TRPV4
Our previous data demonstrate that both TRPV3 and
TRPV4 are expressed in SW982 synoviocytes, although
TNF-α primed response of SW982 synoviocytes to noxious thermal challengeFigure 2
TNF-α primed response of SW982 synoviocytes to noxious thermal challenge. Effect of TNF-α pre-treatment on 
[Ca2+]i response to noxious (45°C) thermal challenge in SW982 synoviocytes. A and B: representative calcium traces 
recorded from (A) control (vehicle treated) synoviocytes and (B) TNF-α (1 ng/ml, 8 hr) pre-treated cells. (C) Peak and aver-
age calcium response in control (white bars, n = 7), or TNF-α (1 ng/ml) treated synoviocytes. The TNF-α was added to the 
incubation media for 4 hr (n = 3 trials), 8 hr (n = 4 trials), 12 hr (n = 3 trials), or 16 hr (n = 3 trials) before the experiment.* 
indicates a statistically significant difference (p < 0.05) assessed by ANOVA with Dunnett's test.Page 3 of 16
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abundance semi-quantitatively [11]. In the previous study
we established the thermal threshold (28°C) to which
synoviocytes respond to moderate temperature increase
with increased [Ca2+]i [11]. This is characteristic for
TRPV4, but concurrent TRPV3 activation at ≥ 28°C is also
possible. To further characterize the specificity of synovi-
ocyte "warm" temperature response we monitored
changes in [Ca2+]i during prolonged exposure to 30 or
36°C in the presence or absence of 2-aminoethoxydiphe-
nyl borate (2-AB) which activates and sensitizes TRPV3,
but not TRPV4 [17,18]. Figure 3A, demonstrates that 2-AB
applied after 5 minutes of 30°C stimulation produced no
significant changes in the calcium response slope. Appli-
cation of 2-AB to the bath at room temperature 5–10 min-
utes before thermal stimulation, did not facilitate [Ca2+]i
changes caused by 30 or 35°C temperature (Fig 3B). Like-
wise, no change in calcium flux from baseline was noted
in response to camphor (1, 3, 6, 10 mM), a TRPV3 activa-
tor, either with or without TNF-α pre-treatment (12 hr,
Additional file 1). The combined studies suggest that the
calcium response elicited by "moderate" (30–36°C) ther-
mal stimulation is predominantly mediated by TRPV4,
rather than TRPV3.
It is important to note that average cellular [Ca2+]i contin-
ues to rise while the temperature remains stable at 30°C.
This could be explained by sensitization of thermosensi-
tive channels during continuous stimulation. The large
calcium wave occurring when the temperature is switched
from 30°C to 23°C and 2-AB is removed from the cham-
ber, could be explained by the activation of TRPM8 chan-
nels since they are reversibly inhibited by 2-AB [18].
TRPM8 responses to menthol are described below.
TNF-α facilitates response to "moderate" temperature 
increase in synoviocytes
Pretreatment of cells with 1 ng/ml TNF-α for 8–16 hours
has no effect on a temperature threshold, assessed by step-
wise bath solution heating with 0.5°C per minute incre-
ments. The [Ca2+]i rise in TNF-α treated cells is observed at≥ 28 ± 2°C,(n = 9), and is not significantly different from
the temperature threshold of vehicle treated cells (29 ±
2°C) (n = 4). However, as shown in Figure 4, TNF-α
caused a significant change in the magnitude of synovio-
cyte response to temperature stimulation above room
temperature (24°C). Figure 4A shows the typical calcium
response to 10 minute thermal stimulation at 36°C. Fig-
ure 4B demonstrates the typical response to stimulation at
36°C in cells also pretreated with TNF-α (1 ng/ml for 8
Response of SW982 synoviocytes to "moderate" temperature increaseFigure 3
Response of SW982 synoviocytes to "moderate" temperature increase. Response of SW982 synoviocytes [Ca2+]i to 
"moderate" (30 and 36°C) temperature increase in the presence (+) or absence (-) of 2-AB. The 30 or 36°C solution was 
applied for 8 minutes. (A) Representative calcium trace shows lack of effect of 2-AB applied after 5 minutes of thermal stimu-
lation. (B) In the treated groups, 2-AB was applied in the perfusion 5–10 minutes before and during thermal stimulation. Peak 
(left) and average (right) calcium response (n = 4 trials for each group).Page 4 of 16
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large peaks were observed. These calcium spikes superim-
posed on an elevated [Ca2+]i of significantly smaller
amplitude are occasionally observed in temperature stim-
ulated synoviocytes that were not treated with TNF-α.
Both average and peak [Ca2+]i elevations induced by 36°C
are larger in TNF-α treated cells, with maximal effect
observed at 8 hr (Fig 4C). There was no TNF-α facilitation
of the synoviocyte "cold" response.
Specificity of temperature responses after TNF-α 
pretreatment
In contrast to TRPV1 thermal responses, pretreatment
with TNF-α did not induce changes in synoviocyte
responsiveness to "cold" activator menthol (100 μM,
TRPM8) or irritant icilin (1 μM, TRPA1). Neither the num-
bers of cells responding to menthol (16–21%) or icilin
(96–100%), nor the average amplitude and duration of
the calcium response for the TNF-α-treated (1 or 50 ng/
ml, 12 hr) group were significantly altered from responses
of the control group (vehicle) (Additional file 1).
Delayed osmotic stress-induced synoviocyte calcium 
response after TNF-α pre-treatment
It is well established that TRPV4 channels in neurons and
other cells respond to decreased extracellular osmolarity
and are thus considered membrane osmotic sensors. To
investigate whether synoviocyte TRPV4 is sensitive to
osmotic stress we initially measured calcium responses to
50% hypoosmotic challenge by rapid change of the phys-
iological bath saline to a 150 mOsm/l solution. Figure 5A
shows the typical Ca2+ change elicited by hypoosmotic
challenge. The small elevation of [Ca2+]i evoked is varia-
ble, is not significantly increased over average baseline
response, and it is not affected by addition of the TRPV4
antagonist ruthenium red (10 μM 5 min pretreatment, Fig
5B).
Extracellular exposure to 50% hypotonic saline (150 mos-
mol/l) after 2, 4, or 8 hr exposure to TNF-α induces some-
what increased [Ca2+]i elevations which are variable in
temporal dynamics, i.e. rapid and/or sustained as seen in
control cultures. The increased [Ca2+]i plateau is observa-
TNF-α modulation of the SW982 synoviocyte [Ca2+]i response to 36°CFigure 4
TNF-α modulation of the SW982 synoviocyte [Ca2+]i response to 36°C. A and B: Representative calcium traces 
recorded from (A) control (vehicle treated) synoviocytes and (B) TNF-α (1 ng/ml, 8 hr) pretreated cells. (C) Peak and average 
calcium response in control (white bars, n = 7) or TNF-α (1 ng/ml) treated synoviocytes. The TNF-α was added to the incuba-
tion media for 4 hr (n = 4 trials), 8 hr (n = 5 trials), 12 hr (n = 5 trials), or 16 hr (n = 4 trials) before the experiment. * indicates 
a statistically significant difference (p < 0.05) tested by ANOVA on ranks.Page 5 of 16
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same experiment. In normal control cells and in the
shorter TNF-α pretreatment experiments (2, 4, 8 hr), the
average fluorescent ratio is not significantly changed by
switching from isotonic (300 mosmol/l) to hypotonic
(150 mosmol/l) conditions (Fig. 5C; 8 hr 0.22 ± 0.002 vs.
0.25 ± 0.017 nM, p > 0.05). Likewise, the peak responses
are not elevated in TNF-α pretreated cells over responses
of untreated cells exposed to hypotonic saline at shorter
times (2, 4, 8 hr). Thus, in non-TNF-α-treated cells and
cells pre-treated with TNF-α for 2–8 hr, TRPV4 is not
responsive as a functional osmotic sensor.
However, to investigate further whether TRPV4 is a func-
tional osmoreceptor in conditions of inflammation, cal-
cium microfluorometric analysis was performed in a
separate study measuring changes in fluorescence emis-
sion ratio of Fura 2-loaded cells after longer exposures (12
and 16 hr) to TNF-α in clonal human SW982 synovio-
cytes (Fig 6 and Additional file 2). Intracellular Ca2+ mobi-
lization in response to hypoosmolarity (50%, 150
mosmol/l) was significantly elevated in cells pretreated
with TNF-α (1 ng/ml) after 12 and 16 hrs compared to
controls (Fig 6A, C and Additional file 2). The hypotonic
triggered-calcium elevation is blocked significantly by a
non-selective TRPV channel blocker, ruthenium red (RR,
3 μM) compared to the sensitized response at 12 hrs (p <
0.001) and at 16 hrs (p < 0.001) (Fig. 6B, C and Addi-
tional file 2). This indicates that TRPV4's function as an
osmoreceptor is inducible in conditions of inflammation
with a delayed maximal response 12–16 hr after exposure
to TNF-α in these culture conditions.
TNF-α pre-treatment (> 12 hr) increases the number of 
responsive synoviocytes
A larger percentage of cells respond to hypotonic stimula-
tion after TNF-α pretreatment (Fig. 6D and Additional file
2). The percentage is significantly greater both at 12 hr
(61% of total, p < 0.05) and 16 hr (81.08% of total, p <
0.005) compared to responses of the non-treated control
cells (11.46% of total). The increase in number of cells
reacting to hypotonic challenge can be effectively blocked
by bath application of RR at the longer time points (2%,
12 hr; 13.1%, 16 hr, Fig 6D and Additional file 2). This
suggests TNF-α inducible recruitment of cells with the
TRPV4 osmoreceptor occurs after 12–16 hr pretreatment
in the synoviocytes through downstream mechanisms.
Specificity of TRPV4 responses after TNF-α pretreatment
While TNF-α pre-treatment (12 hr) increased responses of
synoviocytes to challenges of moderate thermal and
hypotonic saline, it did not promote responses to a TRPV4
Lack of response to 8 hr hypoosmotic challenge by SW982 synoviocytesFigure 5
Lack of response to 8 hr hypoosmotic challenge by SW982 synoviocytes. Synoviocytes were poorly responsive to 
hypoosmotic challenge after 2, 4, or 8 hr TNF-α pre-treatment A and B: Representative calcium traces show responses to 
50% hypoosmolar saline (150 mOsm/l) (A) in the absence or (B) presence of TRPV4 channel blocker ruthenium red (10 μM, 5 
min pretreatment). (C) Peak and average calcium response to 50% hypoosmotic stimulation in control (n = 11 cells) or TNF-α 
(1 ng/ml, 8 hr) treated (n = 6 cells) synoviocytes.Page 6 of 16
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Delayed response of SW982 synoviocytes to hypotonic challenge 12–16 hr after TNF-α pretreatmentFigur  6
Delayed response of SW982 synoviocytes to hypotonic challenge 12–16 hr after TNF-α pretreatment. (A) Rep-
resentative calcium activity traces show that after prolonged TNF-α pre-treatment (1 ng/ml, 12 hrs), SW982 synoviocytes 
actively responded to 50% hypotonic saline stimulation (150 mOsm/l). (B) A decrease in osmolarity (50%, 10 min) promotes a 
ruthenium red-sensitive (RR 3 μM, 10 min) intracellular calcium elevation in about 11% of the SW982 synoviocytes. TNF-α (1 
ng/ml) pre-treatment for 12 or 16 hr triggers increased intracellular activity in a greater percentage of cells following hypotonic 
bath application (and see Additional file 2). The increased number of activated cells in hypotonic conditions is effectively 
blocked by bath application of ruthenium red (3 μM, 10 min). (C) The bar graphs show average responses (nM) of SW982 syn-
oviocytes after different pretreatments. Hypotonic stimulation alone (50%, 10 min) does not significantly affect the average 
response of SW982 cells. The same hypotonic challenge in cells pre-treated with TNF-α (1 ng/ml) for 12 hr or 16 hr triggers a 
ruthenium red (RR)-sensitive intracellular calcium elevation. TNF-α pretreatment + hypotonic saline vs. non-treatment control 
+ Hypotonic saline, p < 0.001 ##; TNF-α pretreatment + Hypotonic saline vs. TNF-α + RR + Hypotonic saline, p < 0.001 ###. 
(D) Pre-treatment with TNF-α significantly increased the percentage of cells responding to the 50% hypotonic challenge. The 
increase in responsive cells was significantly blocked by ruthenium red. TNF-α pretreatment + Hypotonic saline vs. non-treat-
ment control + Hypotonic saline, 12 h p < 0.05 *; 16 h p < 0.005 **; TNF-α pretreatment + Hypotonic saline vs. TNF-α + RR 
+ Hypotonic saline, 12 h and 16 h p < 0.05 ***. The X-axis marker in (C) and the N numbers of cells shown in (D) apply to 
both panels (C) and (D).
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binds the tyrosine YS site on the third transmembrane
domain to activate TRPV4. Several doses of 4α-PDD (0.1,
0.3, 1, 3 10, 30 μM, bath application) were tested [19] and
no change in calcium mobilization was noted with this
agent. This experiment was repeated in 6 plates, with over
130 cells selected. At the end of experiment, bath applica-
tion of acetic acid (pH 5.5) onto each plate triggered a
strong [Ca2+]i elevation in SW982 synoviocytes, indicating
cells were viable and responsive.
TNF-α increases expression of TRPV1 and TRPV4 mRNA, 
protein and immunostaining in synoviocytes after 8 hr
The increased synoviocyte sensitivity to TRPV1 and TRPV4
activators after pretreatment with TNF-α, with maximal
effect at 8, 12 and 16 hr strongly suggest a TNF-α mediated
up-regulation of TRPV1 and TRPV4 in SW982 synovio-
cytes. To assess the transcriptional effect of TNF-α treat-
ment, quantitative real time RT-PCR experiments with
TRPV1 and TRPV4 specific primers were performed. As
shown in Figure 7, TNF-α (1 ng/ml) induced significant
increases in TRPV1 (two-fold) and TRPV4 mRNA levels at
8 hr. The time course of the TNF-α induced TRPV1 mRNA
increase is coincident with the observed increase in tem-
perature induced calcium response.
The mRNA increase suggested expression of TRPV1 and
TRPV4 protein levels would be increased. Western blot
data indicated that at the 8 hr time point, TRPV1 protein
levels were elevated significantly in the membrane frac-
tion isolated from TNF-α pretreated synoviocytes (Fig
8A), suggesting membrane translocation. TRPV4 levels
were also highest in the membrane fraction but were not
significantly increased at 8 hr (Fig. 8B). However, TRPV4
levels in synoviocytes were significantly increased 12 hr
after pre-treatment with TNF-α compared to untreated
control cells (whole cell, 0.55 + 0.008 vs. 0.44 + 0.01 a.u.,
p < 0.01).
Immunocytochemical localization of TRPV1 and TRPV4
was examined after 8 and 12 hr incubations with TNF-α
(Fig 9). TRPV1 immunostaining in SW982 synoviocytes
was significantly elevated only at the 8 hr incubation time
point after TNF-α compared to TRPV1 in normal cells
(289 ± 34.8 vs. 127 ± 4.9 arbitrary units, a.u., p < 0.01)
(Fig 9C, I). TNF-α stimulated increase in TRPV1 staining
was greatly reduced by co-incubation with TNF-α inhibi-
tor CAY-10500 (5 μM, 8 hr) (Fig. 9D). Increase in TRPV4
immunostaining was not significantly elevated at 8 hr
(252 ± 20.0 a.u.) (Fig 9G, J), but was increased at the 12
hr time point (584 ± 53.7 vs. 221 ± 21.6 a.u., p < 0.05)
(Fig 9H, J). Cytotoxicity of the CAY-10500 inhibitor with
the prolonged 12 h incubations did not allow testing for
reduction of the TRPV4 increase seen at 12 hr. The TRPV1
and TRPV4 were localized around the nucleus in rough
endoplasmic reticulum indicating synthesis, as well as in
the cell cytoplasm. Membrane localization is supported
by the functional [Ca2+]i and Western blot cell fraction
data. After 12 hr TNF-α treatments, SW982 synoviocytes
assumed a more flattened appearance with an increase in
cell area (1772 ± 203.1 vs. 1246 ± 106.1 um2) (Fig 9K)
and observed nuclear area, suggesting increased cellular
activity that corresponds with the perinuclear staining and
increased responsiveness. Average cell diameter was sig-
nificantly increased at 12 hr (Fig. 9I–K) and cells resume
their original size and stain density 16 hr after TNF-α
treatment. Cell and nuclear integrity are maintained
throughout all time points, and cell proliferation contin-
ues.
The SW982 synoviocyte staining for TRPV1 is coincident
with the peak physiological responses (8 hr). The delay in
increased responsivity to TRPV4 (Fig 6) occurs at the peak
of expression, staining and cell area increases (12 hr).
Discussion
In the present study we demonstrated up-regulation of
two members of the TRP cation channel family in SW982
human synovial cells after preincubation with TNF-α. The
TNF-α induced increases in TRPV1 and TRPV4 gene and
protein expression at 8 and 12 hr respectively, are coinci-
dent with significant enhancement of responses to
TNF-α induces TRPV1 and TRPV4 gene expression increases in synoviocytFigure 7
TNF-α induces TRPV1 and TRPV4 gene expression 
increases in synoviocytes. The SW982 cells when stimu-
lated with 1 ng/ml TNF-α had increased TRPV1 and TRPV4 
gene expression levels over time. The cells were harvested at 
0, 4, and 8 hr for RNA extraction and analysis using quantita-
tive RT-PCR analysis. Relative expression was compared to 
controls normalized at the same time point and assigned a 
value of 1. Each PCR reaction was normalized to the β-actin 
internal control. * indicates a statistically significant difference 
(p < 0.05) tested by ANOVA on ranks.Page 8 of 16
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ated by TRPV1 and TRPV4. These two TRP channels
appear to be the major thermal and osmosensors in syn-
oviocytes. Marginal facilitation of the calcium response at
30°C, in synoviocytes incubated with 2-AB demonstrates
the potential for TRPV3 mediated response to thermal
stimuli in some circumstances, although no response to
camphor was generated. TNF-α did not induce a change in
synoviocyte responsiveness to TRPA1 (icilin) or TRPM8
(menthol) activation.
A number of endogenous factors can activate TRPV1 and
TRPV4 during inflammation (for review see [3,10]). This
includes factors generated in vast amounts during inflam-
mation, i.e. direct ligands such as protons, temperature
increases, lipid mediators and hypoosmolarity, or indirect
activators such as cytokines, bradykinin, ATP, serotonin or
PGE2 [8]. We have previously shown responsiveness of
synoviocytes to capsaicin, resiniferatoxin and icilin [11].
The increased levels of extra-physiologically activated
TRPV1 and TRPV4 channels caused by incubation with
TNF-α can significantly contribute to the activation of syn-
oviocytes observed in joint inflammation. Like other
fibroblasts, the fibroblast-like synoviocytes secrete TNF-α
[20], as well as express its receptors [13]. It is highly likely
that TNF-α increases expression of TRPV1 and TRPV4 by
mediating the up-regulation directly and/or through initi-
ation of downstream events since the inhibitor reduced
the immunostaining increase. Further studies are
required, however.
Sensitization of TRPV1 and TRPV4 was demonstrated
after TNF-α exposures with increased cell responsiveness
to chemical agonist capsaicin, noxious thermal and
TNF-α increases of TRPV1 protein expression in SW982 synoviocytesFigure 8
TNF-α increases of TRPV1 protein expression in SW982 synoviocytes. (A) Western Blot analysis was done on 
whole cell and subcellular protein fractions extracted from synoviocytes. The TNF-α stimulated increase in expression of 
TRPV1 protein was significant at 8 hr in the membrane fraction (n = 3 trials), implying a functional role for TRPV1 in the 
inflamed joint. (B) While TRPV4 mRNA was elevated in the RT-PCR analysis at 8 hr (Fig. 7), a significant increase in TRPV4 
protein was not yet evident at the 8 hr time point tested. * indicates a statistically significant difference from control synovio-
cyte cultures (p < 0.05) tested with unpaired Student's t-test.Page 9 of 16
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fraction of the cultured clonal synoviocytes had increased
responsiveness to capsaicin, as all cells demonstrated
increased [Ca2+]i in response to noxious temperature and
icilin. It is also unclear why the synoviocytes readily
responded to hypoosmolarity but not to TRPV4 agonist
4α PDD. This heterogeneous response suggests that these
TRP channels exist in multi-potential functional states,
that non-neural cellular responses are not identical to
neuronal responses, and/or that tertiary protein structure
plays a role in activation properties. Other mechanisms
regulating TRP channel sensitization may be involved,
such as PKC or PKA dependent phosphorylation [8,9,21-
24] or phosphatidylinositol phosphate binding [1,25].
Further studies detailing the molecular mechanisms of
TNF-α induced increase of TRPV1 and TRPV4 mediated
response in synoviocytes are needed.
Specificity of the TNF-α induced sensitization for TRPV1
and TRPV4 responses was demonstrated. No significant
change in calcium flux from baseline and numbers of syn-
oviocytes responding was noted after TNF-α pre-treat-
ment (12 hr) for menthol, a TRPM8 activator or camphor,
a TRPV3 activator. While almost all of the cells responded
Delayed TNF-α induced increases in TRPV1 and TRPV4Figur  9
Delayed TNF-α induced increases in TRPV1 and TRPV4. Immunocytochemistry reveals an increase of TRPV1 and 
TRPV4 in human SW982 synoviocytes stimulated with 1 ng/ml TNF-α over time. (A) No staining is evident in peptide blocked 
controls: anti-TRPV1 pre-adsorbed with P-19 peptide (B) TRPV1 immunostaining in control cultures. An example of TRPV1 
protein accumulation in a long cellular process is evident in one cell. (C) TRPV1 immunoreactivity is elevated after 8 hr incuba-
tions with TNF-α the TRPV1 staining has a cytoplasmic and perinuclear distribution indicating its synthesis in the rough endo-
plasmic reticulum. (D) TNF-α stimulated increase in TRPV1 staining was greatly reduced by co-incubation with TNF-α 
inhibitor (CAY10500, 5 μM, 8 hr). (E) No staining is evident in peptide blocked controls: anti-TRPV4 pre-adsorbed with pep-
tide 853–871 (1:1, w/w, for 30 min). (F) TRPV4 immunostaining in control cultures. (G) At 8 hr, TRPV4 immunoreactivity is 
not increased. (H). TRPV4 immunostaining is enhanced after 12 hr of TNF-α stimulation compared to untreated cell cultures. 
(I) TRPV1 stain density was significantly increased at 8 hr. Other time points were observed visually, but not quantified. (J) 
TRPV4 stain density was significantly increased at 12 hr and significantly decreased at 16 hr. (K) The bar graph indicates that 
the synoviocyte cell areas are significantly increased at the same time point when TRPV4 staining is increased (12 hr). * indi-
cates p < 0.05 compared to normal synoviocytes. # indicates p < 0.01 compared to normal synoviocytes. Data is representa-
tive of n = 3 experiments.Page 10 of 16
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properties of the synoviocytes to the TRPA1 stimulation.
Lack of response to camphor and lack of sensitization of
the menthol response provide evidence in agreement with
Kochukov et al. [11] that TRPV3 and TRPM8 are mini-
mally expressed in this human SW982 synoviocytes cell
line. Thus, TNF-α sensitized thermal and hypoosmotic
responses of the synoviocytes are mediated primarily by
TRPV1 and TRPV4 activation respectively.
The present study was performed on the human SW982
synovial sarcoma cell line, which a number of studies
have shown share similar physiological properties,
cytokine expression and regulation profiles with primary
human type B synovial cells. Our previous data demon-
strate the functional expression of TRPV1, TRPV4 and
other TRP channels in both SW982 cells and primary
human synoviocytes [11]. In all aspects the results were
similar for the clonal and primary cells. The presence of
functional TRPV1 in human synovial and dermal fibrob-
lasts has been confirmed by other authors [26,27]. In a
separate study we also demonstrated close similarity
between primary human synoviocytes and SW982 cells in
the functional expression of a G-protein coupled mem-
brane acid sensing receptor [28].
Many previous studies describing TRP channel up-regula-
tion have been performed on neuronal cells, where TRPV1
and/or TRPV4 sensitization are shown to be an important
mechanism contributing to chronic hyperalgesia [8,29-
33], bronchial hyper-responsiveness [34], neurogenic
bladder [35], and neurogenic inflammation [9,36-39] (for
detailed review [3,10]). In contrast, TRP channel function
and regulation in non-neuronal cells such as synovial
fibroblasts are less well studied, although the physiologic
contribution of TRPV1 in experimental arthritis has been
well documented recently using TRPV1-knockout mice
[8,31,40-42]. Abundant expression of TRPV1 in human
synovial cells and its up-regulation in the membrane frac-
tion with prolonged TNF-α exposure support our hypoth-
esis that non-neuronal TRP channels are participants in
development of peripheral inflammation.
Our current study demonstrates increased TRPV4 medi-
ated calcium mobilization in response to hypotonicity in
synoviocytes. However, we did not initially observe signif-
icant changes in hypotonicity-induced calcium response
in synoviocytes after TNF-α co-stimulation at 2, 4, and 8
hr, despite the moderate temperature sensitization. Upon
further study, however, the functional consequences of
TRPV4 up-regulation by TNF-α become evident after 12 hr
and persisted through 16 hr of study. The average ampli-
tude of the TRPV4 activated calcium responses was signif-
icantly elevated and was blocked by ruthenium red. The
numbers of cells responding to hypoosmotic stimuli were
greatly increased 3-fold at 12 hr and 4.5-fold at 16 hr.
The role of TRPV4 in synoviocytes is less clear as is the
delay in activation response. Edema is a cardinal sign of
inflammation and osmolarity changes may be a factor.
The delayed TRPV4 sensitization at 12 hr was coincident
with increased TRPV4 immunostaining and protein con-
tent, and development of a flattened appearance of the
cells. These increases became evident when TRPV1 stain-
ing had returned to normal levels. A universal role for
TRPV4 in osmosensation and mechanotransduction has
been promoted in recent studies based on emerging data
from neural cells, epithelia, mesenchymal cells, kidney
and osteoclasts ([2], reviewed in [43]). It is noted in neu-
rons that simultaneous action of a number of combined
inflammatory mediators is required to achieve sufficient
activation of the cAMP pathway to allow TRP-dependent
hyperalgesia to occur [8]. The present study demonstrates
that the inflammatory mediator TNF-α which releases a
cascade of other mediators and enzymes is sufficient over
time to promote the shift in synoviocytes to osmoreceptor
mediated through TRPV4.
Surprisingly, the TRPV4 response to 4α PDD was absent
in the human synoviocytes. This difference may be
explained by distinctive properties of synoviocyte TRPV4
as heterogeneity of this channel due to alternative splicing
and heteromultimerization has been reported [44]. The
TRPV4 transmembrane segment TM3 is a crucial region
for the activation by its most specific agonist 4 alpha-
phorbol 12, 13-didecanoate (4α-PDD). Vriens et al. [45]
have found that mutation of one tyrosine (Tyr555) at the
intracellular N terminal of TM3 (S3) leads to a loss of
responsiveness to 4α-PDD, despite the demonstrated
presence of a functional channel activated by hypotonic
stimulation. This suggests inability of 4α-PDD binding at
the single critical tyrosine in the TM3 segment in human
synoviocytes likely due to the tertiary folding of the pro-
tein in this region as suggested previously [45].
The present data indicate that synoviocytes express func-
tional thermal and osmotic receptors inducible under
inflammatory conditions. The TNF-α mediates up-regula-
tion of TRPV1 and TRPV4, doubling mRNA and protein
expression at 8 and 12 hr, respectively. Microarray data
has been published detailing downstream targets for TNF-
α in synoviocytes [46] and demonstrates regulation of
numerous genes by multiple pathways. Increased expres-
sion of vanilloid channels in the membrane fraction in
the present study implies translocalization of TRPV1 and
TRPV4 to the plasma membrane of synoviocytes initiated
in response to the TNF-α. The time course of TNF-α
induced increase in TRPV1 and TRPV4 protein expression
correlates well with the observed TNF-α induced increasesPage 11 of 16
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and cell recruitment.
The literature suggests that TRP expression in epithelial
lining cells may be extremely important in cells that inter-
face with dramatic changes in the external and internal
environment induced by thermal and mechanical stress,
acidity, hypoosmolarity, foreign chemicals and endog-
enous mediators. Synoviocytes are exposed to all of the
above stimuli in the course of routine joint function and
in acute and chronic inflammatory states. The synovio-
cytes are like other fibroblasts that secrete the inflamma-
tory mediator, TNF-α [20], as well as express TNF-α
receptors [13,14]. It is known that the TNF-α can directly
activate TNF-α receptors on peripheral nerve terminals to
amplify hyperalgesic responses [47,48] and release
enzymes causing injurious joint destruction and impaired
biomechanical function [49-51]. The TRPV1 and TRPV4
mediated [Ca2+]i signaling responses of synoviocytes dur-
ing inflammation would participate in the TNF-α medi-
ated functions that promote the painful inflammatory
and joint destruction processes locally and impact subse-
quent responses of the immune system. The data suggest
TRPV1 and TRPV4 play important roles mediating the
intracellular Ca2+ increase that drives critical functions
such as associated proliferative and secretory responses of
synoviocytes during joint inflammation thus promoting
TRPV1 and TRPV4 as attractive potential therapeutic tar-
gets.
Conclusion
This paper confirms a physiological role for TRP cation
channels in transduction of relevant information to syno-
vial lining cells. The inflammatory milieu includes ther-
mal, osmolar, acidic and mediator stimuli, all potent
activators of TRP channels. Our study supports an induci-
ble responsivity for TRP cation channels TRPV1 and
TRPV4 in synoviocytes to inflammatory mediator, TNF-α.
Pretreatment of human synoviocytes with TNF-α pro-
duces (1) increased TRPV1 and TRPV4 mRNA expression
at 8 hr, (2) increased TRPV1 protein expression at 8 hr in
the membrane fraction, (3) increased TRPV4 cellular
expression and increased cell size at 12 hr, and (4) differ-
entially enhanced calcium responsiveness and cell recruit-
ment in response to thermal and osmolarity challenges.
Responses of synoviocytes depend on the TRP stimuli and
time point after TNF-α exposure. The delayed transduc-
tion and responsivity are highly suggestive of downstream
transcriptional regulation. This study emphasizes the
need for studies designed with prolonged time courses to
better understand clinically relevant physiological
responses of local cells that impact inflammatory pain
states. These findings further support augmented rele-
vance of synoviocyte TRP ion channels in arthropathies,
and potentially other non-neuronal TRP responses in
inflammatory states.
Methods
Cell lines and cultures
The fibroblast-like synovial SW982 [42] cells were
obtained from the American Type Culture Collection
(ATCC, Bethesda, MD) and maintained in Leibovitz's L-
15 medium (GIBCO, Grand Island, NY), 10% heated fetal
bovine serum (FBS, Gemini Bio-Products, Woodland,
CA), 2 mM L-glutamine, 1,000 U/ml penicillin G
(GIBCO), and 100 ng/ml streptomycin (GIBCO). Cells
were incubated in a humidified cell incubator (37°C,
ambient CO2). Low passage cells (3–15×) were used in
this study.
Cytosolic free calcium ([Ca2+]i) measurement
For measurement of [Ca2+]i in cells exposed to chemical
activators of different TRP channels a fluorescent calcium
imaging approach was used. Cells were harvested with
0.25% trypsin-0.02% EDTA disruption, plated on 15-mm
circular quartz glass coverslips at a density of 200,000
cells/mm3 and incubated at 37°C for 24–48 h before an
experiment. On the day of the experiment, the cells were
loaded with the calcium-sensitive fluorescent dye fura-2
as previously described [11]. Fluorescent recording of
temperature-induced calcium changes was performed as
described earlier [11] using Nikon Diaphot microscope
with an 60× water immersion lens and Till Photonics
Polychrome II photometry setup (Munich, Germany)
equipped with Hamamatsu R928 photomultiplier and
CL-100 bipolar temperature controller with a SC-20
inline solution heater/cooler (Warner Instruments, Ham-
den, CT) and controlled by ITC-18 computer interface
(Instrutech, Port Washington, NY) and X-chart soft-
ware(HEKA, Heidelberg, Germany). Experiments were
repeated a minimum of four times each. The 340-to-380
ratios acquired from single or two-three neighboring cells
every 200 ms were converted into [Ca2+]i with the formula
[Ca2+]i = Kd [(R-Rmin)/(Rmax - R)](Sf2/Sb2)[52], in which
fluorescence ratio sat zero free Ca2+ (Rmin) and saturation
free Ca2+ (Rmax), as well as fluorescent intensity of Ca2+-
free (Sf2) and Ca2+-bound(Sb2) dye, excited at 380 nm,
were measured experimentally and fura-2 Kd values for
Ca2+ at different temperatures were calculated in accord-
ance Shuttleworth and Thompson estimations [53]. Each
calcium trace was evaluated individually and the response
was considered positive when the elevation in [Ca2+]i was
clearly seen at the appropriate time and when the [Ca2+]i
returned to baseline in the absence of treatment. Detec-
tion threshold of [Ca2+]i changes was dictated by signal to
noise ratio and was at least 10 nM over the baseline. Peak
and average amplitude of [Ca2+]i changes over a baseline
were used for quantitative estimation of calcium response.
For simultaneous measurement of [Ca2+]i in large num-
bers of cells exposed to chemical activators of different
TRP channels, human SW982 synoviocytes were plated
onto 12 mm coverslips, cultured for 24 hr, then pre-Page 12 of 16
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the calcium-sensitive fluorescent dye fura-2 for 30–60
min before calcium recording. The activation was done on
3 plates with over 60 cells selected. The imaging setup
included a Nikon 200E microscope with a 20× SuperFluo
lens, and a computer-controlled illumination system
(Sutter Instruments, Novato, CA) equipped with a digital
monochrome-cooled charge-coupled device RoperCool-
snap HQ camera (Roper Scientific, Tucson, AZ). Fluores-
cent emission at 510 nm from regions of interest
(corresponding to a single cell) was acquired online with
the MetaFluor software (Universal Imaging, Downington,
PA). The signal was obtained in dual, 340 and 380 nm,
excitation mode and average intensity of fluorescence in
each region after were used to estimate 340-to-380 ratios.
The elevation in calcium influx for the individual and
population data was considered an increased response if
statistically different from the baseline.
Chemicals
The fluorescent intracellular calcium release indicator
fura-2AM was obtained from Molecular Probes (Eugene,
OR). TRPV1 agonist (capsaicin) and antagonists (cap-
sazepine and 2-aminoethoxydiphenyl borate (2-AB; also
antagonizes TRPV3 but not TRPV4, inhibits TRPM8), were
obtained from Tocris (Ellisville, MO), as was the icilin
(TRPA1 agonist). The ruthenium red (RR, TRPV1 and
TRPV4 antagonist), 4-α-phorbol 12, 13-didecanoate (4α-
PDD, TRPV4 antagonist), and camphor (TRPV3 agonist)
were obtained from Sigma (St. Louis, MO). L-menthol
(TRPM8 agonist) was obtainedfrom Aldrich (Milwaukee,
WI). The inflammatory cytokine tumor necrosis factor
alpha (TNF-α) was obtained from Calbiochem (San
Diego, CA). The TNF-α inhibitor CAY10500 (6,7-dime-
thyl-3-{[methyl-[1-(3-trifluoromethyl-phenyl)-1 H-
indol-3-ylmethyl]-amino}-ethyl)-amino]-methyl-
chromen-4-one) was obtained from Cayman Biologicals
(Ann Arbor, MI). Thapsigargin used to test cytosolic cal-
cium release at the end of each study was obtained from
Calbiochem (La Jolla, CA).
Real time PCR
The low passage SW982 cell cultures were grown in 75
mm flasks until they reached 70–80% confluency. Leibo-
vitz's L-15 Medium (Invitrogen, Carlsbad, CA) with 10%
FBS, 1% P/S was used for culture medium and the cells
were incubated at 37°C, room air, per ATCC recommen-
dations. For the experiments, TNF-α (1 ng/ml) was added
to the designated flasks. The cells were harvested by dis-
ruption (see below) over a time course of baseline (imme-
diately after TNF-α addition), and at 4 and 8 hours after
addition. Flasks containing untreated cells were also har-
vested at the same time as baseline controls. These studies
were performed in three separate experiments.
Total RNA was isolated using Trizol reagent (Cat#
10296028, Invitrogen) in accordance with manufacturer's
protocol. First-strand cDNAs were synthesized from total
RNA by RT using the SuperScript® III First-Strand kit (Cat#
18080051, Invitrogen) with random hexamer primers as
described by the manufacturer. Two microgram of total
RNA from each individual sample was used to synthesize
cDNA for TRPV1, TRPV4 and β-actin, respectively.
Quantitative real-time PCR analysis was performed by the
use of an Applied Biosystems 7000 Sequence Detection
System (Applied Biosystem Inc, Foster City, CA). Each
sample was analyzed in triplicate and the means were
used for statistical purposes. The thermal profiles were
obtained by using 2 min incubation at 50°C, followed by
an initial 10 min denaturation step at 95°C, and by 40
cycles of 1 min each at 60°C plus 15 sec at 95°C. Signifi-
cant contamination with genomic DNA was excluded by
amplifying non-reverse-transcribed RNA.
The probes and primers for TRPV1 (Hs00218912_m1),
TRPV4 (Hs00540967_m1) and β-Actin (Hs99999903-
m1) were ordered from Applied Biosystem Inc. The
threshold cycle (Ct), i.e. the cycle number at which the
amount of amplified gene of interest reached a fixed
threshold, was determined subsequently. Relative TRPV1
and TRPV4 mRNA expression was calculated by the com-
parative Ct method described elsewhere ()[54]. Analysis
of relative gene expression data using real time quantita-
tive PCR and the 2-Ct method. The relative quantitative
value of target, normalized to an endogenous control β-
actin gene and relative to a control, is expressed as 2-ΔΔCt
(fold), where ΔCt = Ct of target gene (TRPV1 or TRPV4)-
Ct of endogenous control gene (β-actin), and ΔΔCt = ΔCt
of samples for target gene-ΔCt of the control for the target
gene. 2 μl of synthesized cDNA from each individual sam-
ple was used to amplify for TRPV1, TRPV4 and β-actin,
respectively.
Western blot analysis
Low passage SW982 cell cultures were grown in 75 mm
flasks until they reached 70–80% confluency. Proteins
were extracted from control cultures without treatment
and after treatment with 1 ng/ml TNF-α (Pierce Biotech-
nology, Inc., Rockford, IL) for 8 hours. Western Blot anal-
ysis was performed on whole cell protein and subcellular
protein fractions extracted from synovial SW982 cells with
ProteoExtract Subcellular Proteome Extraction kit (Calbi-
ochem). Protein transferred to membranes were probed
with anti-TRPV1 antibody (VR1, P-19, 1:1000, Santa
Cruz, Burlingame, CA) and TRPV4 (VR4, K-18, 1:200,
Santa Cruz) antibody, at 4°C overnight. Amounts of total
protein loaded per lane: 15 μg for cytosolic and mem-
brane fractions, 10–15 μg for whole cell and 5 μg for ratPage 13 of 16
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sis was performed with protein from three experiments.
Immunocytochemistry
Cells on glass coverslips were fixed with 4% freshly mixed
paraformaldehyde:methanol (5:1, v/v) for 30 min at
room temperature. The coverslips were washed 3× in PBS
and incubated at room temperature for 30 minutes with
3% neutral serum. The primary antibody (anti-TRPV1,
(1:500, P19: sc-12498, Santa Cruz, Burlingame, CA) or
TRPV4 (1:400, #ACC-034, Alomone, Jerusalem, Israel)
was diluted in TBS with 1.0% neutral serum (0.02% Tri-
ton X-100). The primary antibody was allowed to incu-
bate on the glass coverslips for 48–72 h at 4°C. The glass
coverslips were then washed 3× with 1% serum, 0.02%
Triton X-100 and then incubated for 30–60 min at room
temperature with the appropriate secondary IgG antibody
(1:200, 1 hr), using donkey anti-goat (for TRPV1) and
goat anti-rabbit (for TRPV4). Each had a FITC fluorescent
tag (1:200, Santa Cruz). After final washes 3× with PBS,
the stained coverslips were inverted onto a dot of VectaSh-
ield mounting media containing blue nuclear counter-
stain DAPI. Immunocytochemical controls included the
absence of the primary or secondary antibodies, or were
done in the presence of matched serum at the same dilu-
tion. The specificity of the antibodies was confirmed for
TRPV1 by adsorption controls with P-19 N-terminus pep-
tide provided by Santa Cruz, and for TRPV4 with peptide
853–871 supplied by Alomone Labs (1:1 w/w, 30 min).
There was no staining in either the method controls or the
peptide blocked controls. TNF-α stimulated increase in
TRPV1 was greatly reduced by co-incubation with a TNF-
α inhibitor, CAY10500. Stained cells were visualized with
a Nikon FXA microscope equipped with MetaVue soft-
ware (Nikon Instruments, Inc. Melville, NY).
Software and statistics
Sigma Plot and Sigma Stat scientific software (SPSS, Chi-
cago, IL) were used for conversion and analysis of
acquired data. Data are reported as means ± SE. Meta-
Morph software (Universal Imaging, Downington, PA)
were used for off-line analysis of calcium imaging data.
Student's t-tests or ANOVA for multiple comparisons with
Tukey's multiple comparison post hoc test or Dunnett's
method were used to compare data obtained from TNF-α
treated vs. control series, unless otherwise indicated.
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